Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medipan is a private German in vitro diagnostics company focused on autoimmune and related disease testing. The company develops, manufactures, and markets manual assay kits and automated diagnostic systems, including ELISA, immunofluorescence, radioimmunoassay, lateral flow, and LINE/Dot immunoassays. A notable technology platform is AKLIDES, described by the company as a fully automated system for objective evaluation of cell-based immunofluorescence tests. Medipan operates together with sister company GA Generic Assays and serves laboratories, physicians, medical institutes, and research centers in more than 70 countries. Its portfolio is commercial rather than a drug-development pipeline, with products spanning thyroid, diabetes, rheumatology, gastroenterology, neurology, and complement-related autoimmune diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medipan.